Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

LyondellBasell (LYB) Announces Pricing Of Guaranteed Notes

Published 09/27/2019, 08:38 AM
Updated 07/09/2023, 06:31 AM

LyondellBasell Industries N.V.’s (NYSE:LYB) fully-owned subsidiary, LYB International Finance III, LLC, has priced a public offering of $1 billion total principal amount of 4.2% guaranteed notes due 2049.

The company expects the offering to close on Oct 10, 2019, which is subject to the fulfilment of customary closing conditions. The notes are unconditionally and fully guaranteed by LyondellBasell.

The company is expected to employ the net proceeds from the offering to repay a portion of the outstanding indebtedness under its 364-day $2,000-million senior unsecured term loan facility.

Shares of LyondellBasell have gained 5.2% year to date against the industry’s decline of 21.4%.



In August, the company stated that it anticipates low-cost natural gas liquid feedstocks to continue driving strong chain margin in the Olefins & Polyolefins Americas unit as well as Oxyfuels and Related Products business. The company intends to initiate operations in the Hyperzone HDPE plant during the second half of 2019.

LyondellBasell's HDPE project is expected to boost capacity and drive earnings. The facility will have an annual capacity of 1.1 billion pounds. The company is also constructing a world scale plant on the U.S. Gulf Coast for producing propylene oxide (PO) and tertiary butyl alcohol (TBA). The plant will have annual capacity of 1 billion pounds of PO as well as 2.2 billion pounds of TBA and its derivatives.

The buyout of A. Schulman will also generate significant cost synergies. The integration is progressing well and at the end of second-quarter 2019, the company captured cost synergies at an annual rate of around $100 million.

Zacks Rank & Key Picks

LyondellBasell currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the basic materials space are Kinross Gold Corporation (NYSE:KGC) , Agnico Eagle Mines Limited (NYSE:AEM) and Arconic Inc (NYSE:ARNC) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Kinross has an expected earnings growth rate of 160% for 2019. The company’s shares have surged 88.5% in the past year.

Agnico Eagle has projected earnings growth rate of 157.1% for the current year. The company’s shares have rallied 69.4% in a year’s time.

Arconic has an estimated earnings growth rate of 50% for the current year. Its shares have moved up 19.5% in the past year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


LyondellBasell Industries N.V. (LYB): Free Stock Analysis Report

Agnico Eagle Mines Limited (AEM): Free Stock Analysis Report

Kinross Gold Corporation (KGC): Free Stock Analysis Report

Arconic Inc. (ARNC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.